- Conditions
- Healthy
- Interventions
- Inulin Fiber Supplement
- Dietary Supplement
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Cystic Fibrosis
- Interventions
- Candy Glucose Tolerance Test
- Diagnostic Test
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 10 Years to 21 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Colonic Neoplasms, Colorectal Neoplasms
- Interventions
- EP2101
- Biological
- Lead sponsor
- Epimmune
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 9
- States / cities
- Los Angeles, California • San Diego, California • Orlando, Florida + 6 more
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Infant Formula 1, Infant Formula 2
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 2 Weeks to 9 Weeks
- Enrollment
- 113 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1996 – 1997
- U.S. locations
- 7
- States / cities
- Little Rock, Alaska • Aurora, Colorado • Stone Mountain, Georgia + 4 more
- Conditions
- Liver Disease, Liver Transplantation
- Interventions
- Alemtuzumab, Cyclosporine, Mycophenolate mofetil, Tacrolimus, Liver transplant, Immunosuppression withdrawal
- Drug · Procedure
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2011
- U.S. locations
- 8
- States / cities
- San Francisco, California • Denver, Colorado • Miami, Florida + 5 more
- Conditions
- Healthy, Full-term Infants Who Are Formula-fed
- Interventions
- Routine Infant Formula 1, Routine Infant Formula 2
- Other
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Industry
- Eligibility
- 9 Days to 19 Days
- Enrollment
- 79 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 8
- States / cities
- Pensacola, Florida • Louisville, Kentucky • Owensboro, Kentucky + 5 more
- Conditions
- Herpes Simplex, HIV Infections, Hepatitis B
- Interventions
- Fialuridine
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years to 65 Years
- Enrollment
- 78 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1993
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • San Diego, California • Bethesda, Maryland + 1 more
- Conditions
- Cystic Fibrosis
- Interventions
- Dornase alfa, placebo
- Drug
- Lead sponsor
- Genentech, Inc.
- Industry
- Eligibility
- 14 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 40
- States / cities
- Birmingham, Alabama • Los Angeles, California • Orange, California + 36 more
- Conditions
- Gastric Cancer
- Interventions
- S-1, cisplatin
- Drug
- Lead sponsor
- Taiho Oncology, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 11
- States / cities
- Los Angeles, California • Honolulu, Hawaii • Chicago, Illinois + 3 more
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Inulin, soluble corn fiber
- Other
- Lead sponsor
- Tate & Lyle
- Industry
- Eligibility
- 3 Years to 9 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Addison, Illinois
- Conditions
- Liver Failure
- Interventions
- Anti-Thymocyte Globulin, ATG (Rabbit), Total lymphoid irradiation
- Drug · Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
- Interventions
- IKS014
- Drug
- Lead sponsor
- Iksuda Therapeutics Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 4
- States / cities
- Newport Beach, California • Boston, Massachusetts • Nashville, Tennessee + 1 more
- Conditions
- Tolerance, Healthy Population
- Interventions
- Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
- Other
- Lead sponsor
- Mondelēz International, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Addison, Illinois
- Conditions
- Complex Conditions, Including Impairment of the GI Tract
- Interventions
- Neocate Infant and Junior marketed products
- Dietary Supplement
- Lead sponsor
- Nutricia Research
- Industry
- Eligibility
- Up to 10 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia • Greenville, South Carolina
- Conditions
- Infant, Gastrointestinal Intolerance
- Interventions
- Experimental Hydrolyzed infant formula
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- Up to 180 Days
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 3
- States / cities
- Indianapolis, Indiana • Cleveland, Ohio • Huber Heights, Ohio
- Conditions
- Premature Infant
- Interventions
- No gastric residual evaluation
- Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- Up to 3 Days
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Celiac Disease
- Interventions
- larazotide acetate, placebo, 900 mg gluten
- Drug · Dietary Supplement
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 72 Years
- Enrollment
- 171 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 17
- States / cities
- Scottsdale, Arizona • Colorado Springs, Colorado • Chicago, Illinois + 14 more
- Conditions
- Short Gut Syndrome
- Interventions
- Green bean puree
- Dietary Supplement
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 4 Months to 18 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis
- Interventions
- Not listed
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 6 Years and older
- Enrollment
- 79 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2010
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Infant Formula supplemented with Oligosaccharides
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 7 Days to 42 Days
- Enrollment
- 69 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Tucson, Arizona + 10 more
- Conditions
- Acute Pancreatitis (AP), Enhancing Enteral Nutrition Tolerance
- Interventions
- RELiZORB digestive enzyme (immobilized lipase) cartridge
- Device
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 5
- States / cities
- Bay Shore, New York • Manhasset, New York • Manhattan, New York + 2 more
- Conditions
- Cystic Fibrosis, Pancreatic Insufficiency
- Interventions
- GLP-1, GIP
- Drug
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 45 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Cystic Fibrosis
- Interventions
- Acute Antioxidant, Chronic Antioxidant, Placebo
- Dietary Supplement · Other
- Lead sponsor
- Augusta University
- Other
- Eligibility
- 7 Years and older
- Enrollment
- 13 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2027
- U.S. locations
- 1
- States / cities
- Augusta, Georgia
- Conditions
- Cystic Fibrosis, Prediabetes
- Interventions
- Sitagliptin
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 13 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2017
- U.S. locations
- 3
- States / cities
- Atlanta, Georgia • Columbus, Ohio